Results 131 to 140 of about 130,251 (209)

Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis. [PDF]

Front Mol Biosci
Bai J, Wan Z, Zhou W, Wang L, Lou W, Zhang Y, Jin H.   +6 more
europepmc   +1 more source

The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma. [PDF]

Sci Rep
Katt WP, Balkman CE, Butler SD, Byron M, Carney PC, Todd-Donato AB, Drozd ME, Duhamel GE, Evans JM, Fiani N, Ford JC, Grenier JK, Hayward JJ, Heikinheimo K, Hume KR, Moore ES, Puri R, Sylvester SR, Warshaw SL, Webb SM, White AC, Wright AL, Cerione RA, Peralta S.   +23 more
europepmc   +1 more source

Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation. [PDF]

Molecules
Ren X, Yang Y, Wang M, Yuan Q, Suo N, Xie X.   +5 more
europepmc   +1 more source

Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic Options. [PDF]

J Clin Med
Ambrogio F, Perillo T, Bonamonte D, De Marco A, Tirone B, Laface C, Cazzato G, Foti C, Mortato E.   +8 more
europepmc   +1 more source

MEK/Aurora Kinase Inhibitor BI 847325 [PDF]

, 2020
openaire   +1 more source

Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study. [PDF]

Cancer Immunol Immunother
Beckmann M, Schlüter J, Erdmann M, Kramer R, Cunningham S, Hackstein H, Zimmermann R, Heinzerling L.   +7 more
europepmc   +1 more source

Cost per outcome of nivolumab + relatlimab vs BRAF + MEK inhibitor combinations for first-line treatment of <i>BRAF</i>-mutant advanced melanoma. [PDF]

J Manag Care Spec Pharm
Hanna KS, Palaia J, Patel D, Moshyk A, Zhou ZY, Yang F, Xin Y, Garcia-Horton V.   +7 more
europepmc   +1 more source

SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells. [PDF]

Front Immunol
Bernhardt M, Rech A, Berthold M, Lappe M, Herbel JN, Erhard F, Paschen A, Schilling B, Schlosser A.   +8 more
europepmc   +1 more source

MEK-1/MEKK-1 Inhibitor E6201 [PDF]

, 2020
openaire   +1 more source

Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation. [PDF]

Acta Neuropathol Commun
Steininger J, Buszello C, Oertel R, Meinhardt M, Schmid S, Engellandt K, Herold S, Stasik S, Ebrahimi A, Renner B, Thiede C, Eyüpoglu IY, Schackert G, Beissert S, Meier F, Radke J, Westphal D, Juratli TA.   +17 more
europepmc   +1 more source